Sudha Parasuraman Selected Research

mavorixafor

1/2022	Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma.
1/2021	A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sudha Parasuraman Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 12/2016
3	Neuroblastoma 05/2017 - 11/2013
2	Fatigue 01/2022 - 05/2017
2	Exanthema (Rash) 01/2022 - 01/2021
2	Venous Thromboembolism 02/2010 - 12/2007
1	Diarrhea 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Autoimmune Hepatitis 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Rhabdoid Tumor (Rhabdoid Tumors) 05/2017
1	Thrombocytopenia (Thrombopenia) 05/2017
1	Retinoblastoma (Glioblastoma, Retinal) 05/2017
1	Lymphoma (Lymphomas) 12/2016
1	Genetic Translocation (Chromosomal Translocation) 10/2015
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2015
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2011

Drug/Important Bio-Agent (IBA)

4	ribociclibIBA 05/2017 - 11/2013
2	mavorixaforIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2013
2	Cyclin DIBA 05/2017 - 11/2013
2	Warfarin (Coumadin)FDA LinkGeneric 02/2010 - 12/2007
1	pembrolizumabIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	NivolumabIBA 01/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2017
1	binimetinibIBA 04/2017
1	Cyclin-Dependent Kinase 4IBA 12/2016
1	Retinoblastoma ProteinIBA 12/2016
1	Small Interfering RNA (siRNA)IBA 10/2015
1	Cyclin D1IBA 10/2015
1	Proto-Oncogene Proteins c-etsIBA 10/2015
1	Cell Cycle ProteinsIBA 11/2013
1	Bendamustine Hydrochloride FDA Link 09/2011
1	Bortezomib (Velcade)FDA Link 09/2011
1	Rituximab (Mabthera)FDA Link 09/2011
1	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010
1	Fondaparinux (Arixtra)FDA Link 12/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2013